OMCL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Omnicell Inc (OMCL) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with declining net income and EPS, and insider selling is significantly increasing. While there is optimism around the Titan XT product launch, the financials and mixed analyst sentiment suggest waiting for further clarity on growth execution before investing.
The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 76.539, and moving averages are converging. The stock is trading near its resistance level (R2: 38.653) in pre-market, suggesting limited immediate upside potential.
Analysts have shown optimism about the Titan XT product launch, which could drive future growth. BofA upgraded the stock to Buy with a price target of $70, citing significant upside potential.
Insiders are selling heavily, with a 151.38% increase in selling activity over the last month. Financial performance in Q4 2025 was weak, with net income and EPS showing significant declines. The stock has an 80% chance to drop -18.09% in the next month based on trend analysis.
In Q4 2025, revenue increased by 2.32% YoY to $313.98M, but net income dropped by -112.79% YoY to -$2.03M. EPS fell by -114.71% YoY to -$0.05, and gross margin declined by -10.87% YoY to 41.51%.
Mixed sentiment among analysts. Piper Sandler lowered the price target to $49 from $63, citing muted 2026 guidance. However, BofA upgraded the stock to Buy with a $70 price target, highlighting potential growth from the Titan XT product launch. Benchmark raised its price target to $60, maintaining a Buy rating.
